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N--t--Butoxycarbamate--N--methyl--O--(2--(2--fluorenylmethyloxycarbamate)ethyl)--hydroxylamine (3).
A cooled (0 o C) solution of compound 2 (1.0 g, 2.9 mmol), triphenylphosphine (916 mg, 3.5 mmol), and N--t--butyloxycarbamate--N--methylhydroxylamine (426 mg, 2.9 mmol) in DCM (50 mL) was placed under an atmosphere of Ar. Diisopropyl azodicarboxylate (0.75 mL, 3.38 mmol) was added dropwise to produce a clear solution. The reaction mixture was allowed to warm to RT and after stirring for 9 h, it was quenched by the addition of MeOH. The solution was concentrated under reduced pressure and the resulting oil was purified by flash silica column chromatography using 10% acetone in toluene as the eluent to yield compound 3 (725 mg, 65%) as a thick oil. 1 H (300 MHz, CDCl 3 ) δ 7.75 (d, J = 7.4, 2H, 2 x CH Ar), 7.62 (d, J = 7.4, 2H, 2 x CH Ar), 7.39 (t, J = 7.3 Hz, 2H, 2 x CH Ar), 7.31 (t, J = 7.4 Hz, 2H, 2 x CH Ar), 
N--Methyl--O--(2--(2--fluorenylmethyloxycarbamate)ethyl)--hydroxylammonium chloride (1). Compound 3
(700 mg, 1.7 mmol) was dissolved in 4 M HCl in dioxane (8 mL). After 30 min, diethyl ether (10 mL) was S6 added resulting in the formation of a white precipitate, which was filtered off and washed with ice--cold diethyl ether (20 mL) to yield, after drying in vacuo, compound 1 (406 mg, 70%) as the ammonium 
N--(N--methyl--O--[2--(2--fluorenylmethyloxycarbamate)ethyl]hydroxylamino)--β--D--galactopyransoyl--
Compound 1 (100 mg, 0.29 mmol) and lactose (20 mg, 0.058 mmol) were dissolved in a sodium acetate buffer (0.1 M, pH 4.2). The reaction mixture was stirred for 48 h at 40 o C after which it was concentrated under reduced pressure. The solid residue was purified by reverse phase C18 column chromatography using a gradient of acetonitrile in water (0 --40%) to yield compound 4 (12 mg, 33%) as a white solid. 71, 46.55, 47.91, 60.65, 61.09, 61.12, 66.39, 68.95, 70.15, 71.04, 71.23, 73.46, 76, 76.81, 79.13, 93.94, 103.8, 119.62, 124.89, 126.93, 127. 
N--(N--methyl--O--[2--(2--fluorenylmethyloxycarbamate)ethyl]hydroxylamino)--β--2--acetamido--2--deoxy--D--

glucopyranosyl--(1à3)--β--D--galactopyransoyl--(1à4)--β--D--glucopyranoside (5).
Compound 4 (0.63 µmol) and UDP-GlcNAc (0.94 µmol) were dissolved in HEPES buffer (113 µL, 50 mM, pH 7.3) with KCl (25 mM), MgCl 2 (2 mM), and DTT (1 mM). CIAP (10 mU) and β3GlcNAcT
(27.8 mU/µmol substrate) were added to achieve a final saccharide concentration of 5 mM. The resulting reaction mixture was incubated at 37 °C until no starting material could be detected by MALDI TOF. The reaction mixture was centrifuged and the supernatant was purified by reverse phase C18 column chromatography using a gradient of acetonitrile in water (0-40%). Fractions containing the product were combined and lyophilized to yield compound 5 (0.5 mg, 96%) as a white fluffy solid. 1, 47.51, 48.07, 55.66, 60.41, 60.44, 60.7, 68.24, 69.69, 69.87, 71.23, 73.54, 74.72, 75.54, 76.19, 78.6, 81.88, 92.96, 102.16, 102.84, 103.09, 118.57, 119. 
Compound 5 (0.83 µmol) and UDP-Gal (1.67 µmol) were dissolved in TRIS buffer (128 µL, 50 mM, pH 7.5) containing BSA (1.0% V t ) and CIAP (10 mU, 1.0% V t ). To this solution was added GalT-I (12.0 mU/µmol substrate) to yield a final saccharide concentration of 5 mM. The reaction mixture was incubated at 37 °C until no further starting material was detected by MALDI TOF. The reaction mixture was centrifuged and the supernatant was purified by reverse phase C18 column chromatography using a gradient of acetonitrile in water (0 -40%). Fractions containing the product were combined and lyophilized to yield compound 6 (0.7 mg, 84%) as a white fluffy solid. N/A indicates not assigned [b] --indicates position not available 13 C from HSQC (125 MHz, D 2 O): δ(ppm) 39. 94, 47.05, 55.12, 59.83, 60.95, 68.14, 69.78, 70.91, 71.21, 72.1, 74.57, 74.61, 75.3, 75.48, 76.1, 78.12, 78.64, 81.95, 102.84, 102.97, 120.13, 125.08, 127.49, 148.56, 149 .31. 
MALDI TOF--MS
N--(N--methyl--O--[2--(2--fluorenylmethyloxycarbamate)ethyl]hydroxylamino)--α--5--acetamido--3,5--
dideoxy--D--glycero--α--D--galacto--non--2--ulopyranosonyl acid--(2,3)--β--D--galactopyranosyl--(1à4)--β--2--acetamido--2--deoxy--D--glucopyranosyl--(1à3)--β--D--galactopyransoyl--(1à4)--β--D--glucopyranoside (7).
Compound 6 (0.70 µmol) and CMP-Neu5Ac (1.4 µmol) were dissolved in sodium cacodylate buffer (136 µL, 50 mM, pH 7.6) containing BSA (1.0% V t ) and CIAP (10 mU, 1.0% V t ). To this solution was added ST3Gal-IV (1.92 mU/µmol substrate) to yield a final saccharide concentration of 5 mM. The reaction mixture was incubated at 37 °C until no further starting material could be detected by TLC. Upon completion, the reaction mixture was centrifuged and the supernatant was purified by reverse phase C18 column chromatography using a gradient of acetonitrile in water (0-20%). Fractions containing the product were combined and lyophilized to yield compound 7 (0.7 mg, 78%) a white fluffy solid. N/A -- 10, 45.04, 47.06, 47.48, 47.99, 51.63, 55.09, 60.71, 60.97, 62.49, 67.43, 68.01, 68.25, 68.31, 68.47, 69.35, 69.36, 71.14, 71.70, 72.47, 72.86, 74.5, 74.63, 75.11, 75.46, 75.49, 78.13, 80.88, 82.05, 92.92, 92.92, 102.11, 102.51, 102.69, 102.87, 103.08, 118.6, 119. 2.51 (s, 3H) S10
N--(N--methyl--O--[2--(2--fluorenylmethyloxycarbamate)ethyl]hydroxylamino--β--D--galactopyranosyl--(1à 4)--[α--L--fucopyranosyl (1à 3)]--β--2--acetamido--2--deoxy--D--glucopyranosyl--(1à 3)--β--D--galactopyransoyl--(1à 4)--[α--L--fucopyranosyl (1à 3)]--β--D--glucopyranoside (6S).
Compound 6 (0.6 µmol) and GDP-Fuc (2.39 µmol) were dissolved in TRIS buffer (113 µL, 50 mM, pH 7.3) containing MnCl 2 (10 mM) and CIAP (10 mU, 1.0% V t ). To this solution was added HP α1-3FucT (2.8 mU/µmol of substrate) to yield a final saccharide concentration of 5 mM. The reaction mixture was incubated at 37 °C until no starting material could be detected by MALDI TOF. In the event starting material persisted after 6 h, additional GDP-Fuc and HPα1-3FucT were added. Upon completion, the reaction mixture was centrifuged and the supernatant was purified by reverse phase C18 column chromatography using a gradient of acetonitrile in water (0-40%). Fractions containing the product were combined and lyophilized to yield compound 6S (0.6 mg, 78%) as a white fluffy solid. 07, 24.83, 24.9, 25.27, 38.18, 39.12, 46.92, 55.77, 61.25, 65.95, 66.33, 66.51, 67.52, 67.86, 68.01, 68.18, 68.61, 69.06, 70.43, 70.85, 70.89, 71.32, 71.73, 71.74, 72.3, 72.84, 74.2, 74.75, 74.89, 76.68, 81.43, 92.92, 98.38, 98.43, 101.54, 101.56, 102.32, 119.54, 120.01, 124.34, 124.83, 125.32, 127.36, 127.83, 127.89, 135.01, 135.23, 135.46, 145.11, 145.19 2.51 (s, 3H) S12
N--(N--methyl--O--[2--(2--fluorenylmethyloxycarbamate)ethyl]hydroxylamino--α--5--(acetamindo)--3,5--
dideoxy--D--glycero--α--D--galacto--non--2--ulopyranosonyl acid--β--D--galactopyranosyl--(1à4)--[α--L--fucopyranosyl (1à3)]--β--2--acetamido--2--deoxy--D--glucopyranosyl--(1à3)--β--D--galactopyransoyl--(1à4)--[α--L--fucopyranosyl (1à3)]--β--D--glucopyranoside (8).
Compound 7 (0.31 µmol) and GDP-Fuc (1.24 µmol) were dissolved in TRIS buffer (59 µL, 50 mM, pH 7.3) containing MnCl 2 (10 mM) and CIAP (10 mU, 1.0% V t ). To this solution was added HP α1-3FucT (2.8 mU/µmol of substrate) to yield a final saccharide concentration of 5 mM. The reaction mixture was incubated at 37 °C until no starting material could be detected by TLC. In the event starting material persisted after 6 h, additional GDP-Fuc and HPα1-3FucT were added. Upon completion, the reaction mixture was centrifuged and the supernatant was purified by reverse phase C18 column chromatography using a gradient of acetonitrile in water (0-20%). Fractions containing the product were combined and lyophilized to yield compound 8 (0.4 mg, 82%) as a white fluffy solid. 2.51 (s, 3H) S14
N--(N--methyl--O--[2--(acetamido--LC--biotin)--ethyl]hydroxylamino)--β--D--galactopyransoyl--(1à4)--β--D--glucopyranoside (15).
Deprotected saccharide 4 (1.7 µmol) and EZ-Link® Sulfo-NHS-LC-biotin (5.1 µmol, Pierce Biotechnology) were dissolved in PBS buffer (340 µL, 0.1 M, pH 8.01) to give a glycan concentration of 5 mM. The solution was agitated at RT for 3 h at which time MS showed complete disappearance of the free amine starting material. The reaction mixture was purified by P-2 size exclusion eluting with 5% nbutanol/water solution. Product fractions were pooled and lyophilized to yield compound 15 (1.0 mg, 80%) as a white fluffy powder. 24.92, 27.49, 27.65, 27.88, 35.39, 38.28, 38.98, 39.51, 55.18, 60.04, 60.85, 61.91, 68.38, 69.43, 70.76, 70.80, 72.84, 75.13, 75.89, 76.13, 78.10, 92.89, 102. 
N--(N--methyl--O--[2--(acetamido--LC--biotin)--ethyl]hydroxylamino)--β--D--galactopyranosyl--(1à4)--β--2--
acetamido--2--deoxy--D--glucopyranosyl--(1à3)--β--D--galactopyransoyl--(1à4)--β--D--glucopyranoside (14).
Deprotected saccharide 6 (0.6 µmol) and EZ-Link® Sulfo-NHS-LC-biotin (1.8 µmol, Pierce Biotechnology) were dissolved in PBS buffer (297 µL, 0.1 M, pH 8.01) to give a glycan concentration of 2.5 mM. The solution was agitated at RT for 3 h at which time MS showed complete disappearance of the free amine starting material. The reaction mixture was purified by P-2 size exclusion eluting with 5% nbutanol/water solution. Product fractions were pooled and lyophilized to yield compound 14 (0.5 mg, 75%) as a white fluffy powder. 24.90, 25.38, 27.48, 27.65, 27.83, 35.33, 37.03, 38.11, 38.29, 38.95, 39.47, 39.48, 39.57, 55.03, 55.21, 59.8, 60.07, 60.82, 61.91, 68.18, 68.39, 69.37, 69.80, 70.75, 70.79, 72.02, 72.35, 74.39, 74.76, 75.13, 75.42, 76.16, 77.98, 78.01, 81.89, 92.87, 102.62, 102.71, 102 .79. 2.60 (s, 3H) S16
MALDI TOF--MS
N--(N--methyl--O--[2--(acetamido--LC--biotin)--ethyl]hydroxylamino)--α--5--acetamido--3,5--dideoxy--D--glycero--α--D--galacto--non--2--ulopyranosonyl acid--(2,3)--β--D--galactopyranosyl--(1à4)--β--2--acetamido--2--deoxy--D--glucopyranosyl--(1à3)--β--D--galactopyransoyl--(1à4)--β--D--glucopyranoside (13).
Deprotected saccharide 7 (0.39 µmol) and EZ-Link® Sulfo-NHS-LC-biotin (0.77 µmol, Pierce Biotechnology) were dissolved in PBS buffer (76 µL, 0.1 M, pH 8.01) to give a glycan concentration of 5 mM. The solution was agitated at RT for 3 h at which time MS showed complete disappearance of the free amine starting material. The reaction mixture was purified by P-2 size exclusion eluting with 5% nbutanol/water solution. Product fractions were pooled and lyophilized to yield compound 13 (0.4 mg, 74%) as a white fluffy powder. S17 86, 24.71, 27.30, 27.31, 27.44, 27.66, 35.16, 36.02, 38.14, 38.76, 39.29, 55.02, 55.60, 59.28, 59.37, 59.54, 59.90, 61.14, 61.73, 66.24, 66.32, 67.33, 67.65, 67.91, 68.01, 68.86, 68.93, 70.49, 70.53, 70.58, 70.84, 71.57, 71.97, 72.11, 72.66, 74.04, 74.43, 74.58, 74.77, 76.59, 78.09, 81.24, 92.85, 98.24, 98.26, 101.43, 101.44, 102.19, 155. 
N--(N--methyl--O--[2--(acetamido--LC--biotin)--ethyl]hydroxylamino)--β--D--galactopyranosyl--(1à4)--[α--L--
fucopyranosyl (1à3)]--β--2--acetamido--2--deoxy--D--glucopyranosyl--(1à3)--β--D--galactopyransoyl--(1à4)--[α--L--fucopyranosyl (1à3)]--β--D--glucopyranoside (12).
Deprotected saccharide 6S (0.23 µmol) and EZ-Link® Sulfo-NHS-LC-biotin (0.7 µmol, Pierce Biotechnology) were dissolved in PBS buffer (124 µL, 0.1 M, pH 8.01) to give a glycan concentration of 5 mM. The solution was agitated at RT for 3 h at which time MS showed complete disappearance of the free amine starting material. The reaction mixture was purified by P-2 size exclusion eluting with 5% n- [a] N/A indicates not assigned [b] --indicates position not available 13 C from HSQC (200 MHz, D 2 O) δ (ppm) 21.86, 24.71, 27.3, 27.31, 27.44, 27.66, 35.16, 36.02, 37.91, 38.14, 38.76, 39.29, 55.02, 55.61, 59.37, 59.90, 61.14, 61.73, 66.24, 66.32, 67.33, 67.65, 67.90, 68.01, 68.86, 68.9, 70.49, 70.53, 70.58, 70.84, 71.57, 71.97, 72.11, 72.66, 74.04, 74.42, 74.58, 74.77, 76.61, 77.58, 81.25, 92.85, 98.24, 98.29, 101.43, 101.44, 102.19, 155 
N--(N--methyl--O--[2--(acetamido--LC--biotin)--ethyl]hydroxylamino)--α--5--(acetamindo)--3,5--dideoxy--D--
glycero--α--D--galacto--non--2--ulopyranosonyl acid--β--D--galactopyranosyl--(1à4)--[α--L--fucopyranosyl (1à3)]--β--2--acetamido--2--deoxy--D--glucopyranosyl--(1à3)--β--D--galactopyransoyl--(1à4)−[α--L--fucopyranosyl (1à3)]--β--D--glucopyranoside (11).
Deprotected saccharide 8 (0.32 µmol) and EZ-Link® Sulfo-NHS-LC-biotin (0.95 µmol, Pierce Biotechnology) were dissolved in PBS buffer (63 µL, 0.1 M, pH 8.01) to give a glycan concentration of 5 mM. The solution was agitated at RT for 3 h at which time MS showed complete disappearance of the free amine starting material. The reaction mixture was purified by P-2 size exclusion eluting with 5% nbutanol/water solution. Product fractions were pooled and lyophilized to yield compound 11 (0.4 mg, 75%) as a white fluffy powder. S21 
